Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01622816 · ClinicalTrials.gov registry record
Comparing Visual Acuity Measurements (How Well You Can See) Using a Standard ETDRS Chart & a Handheld ETDRS Chart
A clinical trial of Diabetic Retinopathy, sponsored by Julia Haller.
- Completed
- Registry status
- 70
- Enrollment target
- 1
- Study location
NCT01622816: Completed study of Diabetic Retinopathy, sponsored by Julia Haller.
NCT01622816 is a study of Diabetic Retinopathy that has completed, run by Julia Haller. The registered enrollment target is 70 participants, below the 1,675-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01622816, a study of Diabetic Retinopathy, has completed, sponsored by Julia Haller.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
Comparing visual acuity measurements (measurements of how well you can see) using a standard ETDRS (Early Treatment Diabetic Retinopathy Study) chart and a handheld ETDRS chart
Primary Outcome
To determine the visual acuity measurement using this handheld internally illuminated ETDRS chart, and a standard back illuminated EDTRS chart. This will be done during the visual acuity test.
Conditions Studied
Study Locations (1)
Pennsylvania
- Mid Atlantic Retina- Wills Eye Institute - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2012-03 |
| Est. Completion | 2014-03 |
What the finished NCT01622816 record still lists
NCT01622816 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,675-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Diabetic Retinopathy appearing as the primary indexed condition, and to 0 interventions.
NCT01622816 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01622816 about?
NCT01622816 is a clinical study titled "Comparing Visual Acuity Measurements (How Well You Can See) Using a Standard ETDRS Chart & a Handheld ETDRS Chart". Comparing visual acuity measurements (measurements of how well you can see) using a standard ETDRS (Early Treatment Diabetic Retinopathy Study) chart and a handheld ETDRS chart
What is the current status of trial NCT01622816?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2012-03. Estimated completion is 2014-03.
What conditions does trial NCT01622816 study?
This clinical trial studies the following conditions: Diabetic Retinopathy.
Who is sponsoring clinical trial NCT01622816?
This trial is sponsored by Julia Haller, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01622816 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Retinopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01622816's enrollment target sits among peer trials
70 41st of 57 higher than 17 of 57 other Diabetic Retinopathy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Retinopathy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fenofibrate for Prevention of DR Worsening
RECRUITING · Phase 3
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
RECRUITING
-
Video-based Patient Education Intervention for Diabetic Eye Screening in Latinx Communities
RECRUITING · NA
-
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
RECRUITING · Phase 2
-
Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia